| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2024 | DXCM Dexcom Inc | Leach Jacob Steven55 | EVP Chief Operating Officer | Sell | 3,978 | $123.63 | $491,819.23 | -1.5% | +8.1% | -35.4% | |
| Jan 16, 2024 | DXCM Dexcom Inc | Stern Sadie72 | EVP Chief Human Resources | Sell | 2,902 | $123.63 | $358,788.19 | -3.5% | +8.1% | -35.4% | |
| Jan 16, 2024 | DXCM Dexcom Inc | Sylvain Jereme M65 | EVP Chief Financial Officer | Sell | 2,734 | $123.63 | $338,017.54 | -3.5% | +8.1% | -35.4% | |
| Jan 16, 2024 | OM Outset Medical, Inc. | Nash Marc83 | SVP Operations And R&D | Sell | 678 | $429.00 | $290,862.00 | -0.3% | -50.7% | -81.6% | |
| Jan 16, 2024 | OM Outset Medical, Inc. | Ahmed Nabeel84 | Chief Financial Officer | Sell | 1,726 | $4.29 | $7,404.54 | -0.5% | -50.7% | -81.6% | |
| Jan 16, 2024 | OM Outset Medical, Inc. | Brottem John L.84 | General Counsel | Sell | 1,480 | $4.29 | $6,349.20 | -0.6% | -50.7% | -81.6% | |
| Jan 16, 2024 | DXCM Dexcom Inc | Sayer Kevin R62 | President, CEO And Chairman | Sell | 37,325 | $123.63 | $4,614,668.91 | -9.3% | +8.1% | -35.4% | |
| Jan 16, 2024 | OM Outset Medical, Inc. | Williamson Steven S.83 | Chief Commercial Officer | Sell | 996 | $4.29 | $4,272.84 | -0.3% | -50.7% | -81.6% | |
| Jan 16, 2024 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 8,126 | $4.29 | $34,860.54 | -1.0% | -50.7% | -81.6% | |
| Jan 16, 2024 | OM Outset Medical, Inc. | Racine Jean-Olivier85 | Chief Technology Officer | Sell | 723 | $4.29 | $3,101.67 | -0.3% | -50.7% | -81.6% | |
| Jan 12, 2024 | GKOS Glaukos Corp | Gilliam Joseph E55 | President &COO | Sell | 110 | $89.01 | $9,791.10 | - | +12.2% | +76.9% | |
| Jan 12, 2024 | BSX Boston Scientific Corp | Fitzgerald Joseph Michael51 | EVP &Group Pres, Cardiology | Sell | 11,660 | $60.00 | $699,600.00 | -6.3% | +14.8% | +58.3% | |
| Jan 12, 2024 | ECOR Electrocore, Inc. | Posner Brian M52 | Chief Financial Officer | Buy | 16,000 | $0.00 | - | +248.6% | -2.9% | +168.1% | |
| Jan 12, 2024 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 10,000 | $75.67 | $756,700.00 | -20.2% | +23.5% | -0.8% | |
| Jan 11, 2024 | STIM Neuronetics, Inc. | Sullivan Keith J61 | President And CEO | Sell | 19,529 | $3.08 | $60,209.69 | -0.8% | +36.6% | -46.1% | |
| Jan 11, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 2,477 | $1.14 | $2,811.67 | - | -3.5% | -35.1% | |
| Jan 9, 2024 | BSX Boston Scientific Corp | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 15,172 | $59.25 | $898,941.00 | -21.1% | +16.0% | +62.0% | |
| Jan 9, 2024 | RXST Rxsight, Inc. | Goldshleger Ilya81 | Chief Operating Officer | Sell | 5,000 | $47.00 | $235,000.00 | -15.9% | +22.3% | -25.1% | |
| Jan 9, 2024 | PRCT Procept Biorobotics Corp | Waters Kevin | EVP, CFO | Sell | 17,310 | $45.07 | $780,246.52 | -34.1% | +1.7% | +77.9% | |
| Jan 9, 2024 | PRCT Procept Biorobotics Corp | Nouri Alaleh50 | EVP, CLO, Corp. Sec. | Sell | 16,000 | $44.97 | $719,475.20 | -25.3% | +1.7% | +77.9% | |
| Jan 9, 2024 | PACB Pacific Biosciences Of California, Inc. | Van Oene Mark79 | See Remarks | Sell | 31,012 | $7.77 | $241,056.28 | -3.3% | -55.1% | -72.7% | |
| Jan 9, 2024 | RXST Rxsight, Inc. | Weinberg Eric57 | Chief Commercial Officer | Sell | 10,000 | $46.00 | $460,000.00 | -3.0% | +22.3% | -25.1% | |
| Jan 9, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 6,290 | $1.10 | $6,927.33 | - | -1.8% | -32.8% | |
| Jan 9, 2024 | GKOS Glaukos Corp | Burns Thomas William | Chairman &CEO | Sell | 60,115 | $82.55 | $4,962,694.69 | -9.5% | +16.3% | +82.7% | |
| Jan 8, 2024 | OM Outset Medical, Inc. | Racine Jean-Olivier85 | Chief Technology Officer | Sell | 3,905 | $5.49 | $21,438.45 | -5.0% | -53.0% | -79.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.